086900.KQ

Medy-Tox Inc. [086900.KQ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

086900.KQ Stock Summary

Top 10 Correlated ETFs

086900.KQ


Top 10 Correlated Stocks

086900.KQ


In the News

086900.KQ Financial details

Company Rating
Neutral
Market Cap
1277.86B
Income
10.35B
Revenue
205.39B
Book val./share
72973.04
Cash/share
6137.2
Dividend
952.38
Dividend %
0.4%
Employees
728
Optionable
No
Shortable
Yes
Earnings
05 Mar 2024
P/E
150.38
Forward P/E
-
PEG
-16.49
P/S
7.75
P/B
3.24
P/C
30.55
P/FCF
134.97
Quick Ratio
0.77
Current Ratio
1.38
Debt / Equity
0.01
LT Debt / Equity
0.01
-
-
EPS (TTM)
1.28K
EPS next Y
-
EPS next Q
-
EPS this Y
-62.19%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-13.16%
Revenue last 5Y
-1.03%
Revenue Q/Q
13.26%
EPS Q/Q
-131.69%
-
-
-
-
SMA20
-16.43%
SMA50
-14.51%
SMA100
-34.72%
Inst Own
0%
Inst Trans
0%
ROA
2%
ROE
2%
ROC
0.06%
Gross Margin
63%
Oper. Margin
15%
Profit Margin
5%
Payout
78%
Shs Outstand
6.73M
Shs Float
4.96M
-
-
-
-
Target Price
-
52W Range
182600.0-316500.0
52W High
-40.76%
52W Low
+2.68%
RSI
36
Rel Volume
-
Avg Volume
57.28K
Volume
Perf Week
-0.21%
Perf Month
-21.71%
Perf Quarter
-15.73%
Perf Half Y
-16.11%
-
-
-
-
Beta
0.502
-
-
Volatility
1504.69%, 18948.59%
Prev Close
-0.16%
Price
187500
Change
-1.37%

086900.KQ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
32.63K31.83K21.95K28.8K29.72K
Net income per share
11.11K4.05K-4.61K14.52K5.49K
Operating cash flow per share
8.75K5.21K4.35K3.11K3.99K
Free cash flow per share
7.4K1.96K-2.06K382.012.48K
Cash per share
4.03K3.64K8.67K12.76K3.61K
Book value per share
40.12K40.06K37.63K62.24K65.21K
Tangible book value per share
42.67K38.21K35.97K62.02K65.38K
Share holders equity per share
40.12K40.06K37.63K62.24K65.21K
Interest debt per share
027.4910.17K8.58K3.05K
Market cap
3078.49B1681.53B1018.34B879.64B840.25B
Enterprise value
3059.24B1661.51B974.34B807.86B819.56B
P/E ratio
4464.17-34.439.4423.32
Price to sales ratio
14.988.177.234.764.31
POCF ratio
55.949.8936.4644.0632.07
PFCF ratio
66.1132.59-77.05358.7551.54
P/B Ratio
12.196.494.222.21.96
PTB ratio
12.196.494.222.21.96
EV to sales
14.898.076.924.374.2
Enterprise value over EBITDA
30.1337.91-52.7515.7213.27
EV to operating cash flow
55.5549.334.8940.4631.28
EV to free cash flow
65.69131.01-73.72329.4850.27
Earnings yield
0.020.02-0.030.110.04
Free cash flow yield
0.020.01-0.0100.02
Debt to equity
000.270.140.05
Debt to assets
000.140.10.03
Net debt to EBITDA
-0.19-0.462.38-1.4-0.33
Current ratio
1.050.881.181.491
Interest coverage
00000
Income quality
0.791.29-0.940.210.71
Dividend Yield
000.0100.01
Payout ratio
0.170.17-0.1900.22
Sales general and administrative to revenue
00000
Research and developement to revenue
0.090.130.230.130.12
Intangibles to total assets
0.040.040.030.010.01
Capex to operating cash flow
-0.15-0.62-1.47-0.88-0.38
Capex to revenue
-0.04-0.1-0.29-0.09-0.05
Capex to depreciation
-0.53-1.16-2.21-0.96-0.66
Stock based compensation to revenue
0.0200.010.010
Graham number
100.15K60.42K62.48K142.58K89.74K
ROIC
0.280.1-0.160.050.08
Return on tangible assets
0.180.06-0.070.160.06
Graham Net
-4.4K-12.1K-19.16K-8.44K-12.02K
Working capital
5.62B-16.32B21.12B53.01B-128.34M
Tangible asset value
268.64B247.19B230.74B398.07B429.2B
Net current asset value
5.62B-38.82B-84.25B-13.17B-27.54B
Invested capital
000.270.140.05
Average receivables
51.42B59.54B45.33B31.43B36.85B
Average payables
1.97B3.18B4.05B4.01B3.71B
Average inventory
16.56B25.42B33.44B35.26B42.8B
Days sales outstanding
111.21100.1488.5556.6784.19
Days payables outstanding
15.0921.3521.7818.5217.92
Days of inventory on hand
143.5152.85204.81151.57278.16
Receivables turnover
3.283.654.126.444.34
Payables turnover
24.1817.116.7619.7120.37
Inventory turnover
2.542.391.782.411.31
ROE
0.280.1-0.120.230.08
Capex per share
-1.35K-3.25K-6.41K-2.73K-1.51K

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
8.89K7.68K5.62K6.74K8.92K
Net income per share
2.2K-214.07732.521.11K-353
Operating cash flow per share
1.83K1.09K120.111.4K403.48
Free cash flow per share
1.27K654.68-278.751.07K184.48
Cash per share
8.25K3.48K5.62K6.38K6.14K
Book value per share
74.53K62.89K60.36K62.85K72.97K
Tangible book value per share
74.21K63.06K60.52K62.98K73.14K
Share holders equity per share
74.53K62.89K60.36K62.85K72.97K
Interest debt per share
2.08K2.94K1.98K1.3K760.03
Market cap
621.25B871.24B1681.23B1810.81B1661.12B
Enterprise value
581.03B850.55B1640.05B1761.8B1620.84B
P/E ratio
11.76-149.4975.652.85-178.82
Price to sales ratio
11.6516.6739.434.9728.32
POCF ratio
56.68117.561.84K167.72625.8
PFCF ratio
81.59195.51-794.63219.841.37K
P/B Ratio
1.392.043.673.753.46
PTB ratio
1.392.043.673.753.46
EV to sales
10.916.2738.4334.0227.63
Enterprise value over EBITDA
31.9343.1314.89135.19223.11
EV to operating cash flow
53.01114.771.8K163.18610.63
EV to free cash flow
76.3190.87-775.16213.891.34K
Earnings yield
0.020000
Free cash flow yield
0.010.01000
Debt to equity
0.030.050.030.020.01
Debt to assets
0.020.030.020.020.01
Net debt to EBITDA
-2.21-1.05-7.91-3.76-5.55
Current ratio
1.0511.331.611.38
Interest coverage
00000
Income quality
0.83-15.380.161.26-1.14
Dividend Yield
00.01000
Payout ratio
0-5.52000
Sales general and administrative to revenue
00.01000
Research and developement to revenue
00.45000
Intangibles to total assets
0.010.010.010.010.01
Capex to operating cash flow
-0.31-0.4-3.32-0.24-0.54
Capex to revenue
-0.06-0.06-0.07-0.05-0.02
Capex to depreciation
-0.91-0.86-0.88-0.74-0.39
Stock based compensation to revenue
00000
Graham number
60.78K17.4K31.54K39.69K24.07K
ROIC
0.02000.020
Return on tangible assets
0.0200.010.010
Graham Net
-10.48K-11.6K-4.65K-1.19K-3.43K
Working capital
7.8B-128.34M36.99B60.26B43.98B
Tangible asset value
444.95B429.2B459.32B484.24B481.16B
Net current asset value
-14.76B-27.54B12.59B40.42B29.02B
Invested capital
0.030.050.030.020.01
Average receivables
40.31B43.56B42.66B40.19B44.68B
Average payables
4.07B4B3.7B4.03B3.69B
Average inventory
45.75B50.38B55.2B59.86B62.58B
Days sales outstanding
71.177.4885.0469.6275.64
Days payables outstanding
22.5417.0419.6618.9714.29
Days of inventory on hand
235.84264.51282.85291.23269.83
Receivables turnover
1.271.161.061.291.19
Payables turnover
3.995.284.584.746.3
Inventory turnover
0.380.340.320.310.33
ROE
0.0300.010.020
Capex per share
-558-434.09-398.85-332.91-219

086900.KQ Frequently Asked Questions

What is Medy-Tox Inc. stock symbol ?

Medy-Tox Inc. is a KR stock and trading under the symbol 086900.KQ

What is Medy-Tox Inc. stock quote today ?

Medy-Tox Inc. stock price is $187500 today.

Is Medy-Tox Inc. stock public?

Yes, Medy-Tox Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks